Correlation Between Hemogenyx Pharmaceuticals and SoftBank Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hemogenyx Pharmaceuticals and SoftBank Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hemogenyx Pharmaceuticals and SoftBank Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hemogenyx Pharmaceuticals PLC and SoftBank Group Corp, you can compare the effects of market volatilities on Hemogenyx Pharmaceuticals and SoftBank Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hemogenyx Pharmaceuticals with a short position of SoftBank Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hemogenyx Pharmaceuticals and SoftBank Group.

Diversification Opportunities for Hemogenyx Pharmaceuticals and SoftBank Group

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Hemogenyx and SoftBank is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Hemogenyx Pharmaceuticals PLC and SoftBank Group Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SoftBank Group Corp and Hemogenyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hemogenyx Pharmaceuticals PLC are associated (or correlated) with SoftBank Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SoftBank Group Corp has no effect on the direction of Hemogenyx Pharmaceuticals i.e., Hemogenyx Pharmaceuticals and SoftBank Group go up and down completely randomly.

Pair Corralation between Hemogenyx Pharmaceuticals and SoftBank Group

Assuming the 90 days trading horizon Hemogenyx Pharmaceuticals PLC is expected to generate 19.45 times more return on investment than SoftBank Group. However, Hemogenyx Pharmaceuticals is 19.45 times more volatile than SoftBank Group Corp. It trades about 0.05 of its potential returns per unit of risk. SoftBank Group Corp is currently generating about 0.08 per unit of risk. If you would invest  88,000  in Hemogenyx Pharmaceuticals PLC on October 10, 2024 and sell it today you would lose (49,250) from holding Hemogenyx Pharmaceuticals PLC or give up 55.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy73.2%
ValuesDaily Returns

Hemogenyx Pharmaceuticals PLC  vs.  SoftBank Group Corp

 Performance 
       Timeline  
Hemogenyx Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hemogenyx Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
SoftBank Group Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days SoftBank Group Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively uncertain basic indicators, SoftBank Group may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Hemogenyx Pharmaceuticals and SoftBank Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hemogenyx Pharmaceuticals and SoftBank Group

The main advantage of trading using opposite Hemogenyx Pharmaceuticals and SoftBank Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hemogenyx Pharmaceuticals position performs unexpectedly, SoftBank Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SoftBank Group will offset losses from the drop in SoftBank Group's long position.
The idea behind Hemogenyx Pharmaceuticals PLC and SoftBank Group Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bonds Directory
Find actively traded corporate debentures issued by US companies